Preparation method and application of lactobacillus paracasei IOB413 metagen extract product
The invention provides a preparation method of a Lactobacillus paracasei IOB413 metagen extract product, the Lactobacillus paracasei IOB413 metagen extract product obtained by the method, and an application of the Lactobacillus paracasei IOB413 metagen extract product in preparation of Helicobacter pylori infection resisting related drugs. The lactobacillus paracasei IOB413 metagen extract product obtained by the method disclosed by the invention has the obvious effects of inhibiting the growth of helicobacter pylori, relieving the infection of the helicobacter pylori and improving flora disorder on mice infected by the helicobacter pylori; a certain pharmacological basis can be provided for adjuvant treatment of helicobacter pylori infection according to the casei paracasei IOB413 metaplasm extract product obtained by the method and functional verification of the product; and an effective thought is provided for developing the application of the lactobacillus paracasei IOB413 metagen extract product in the anti-helicobacter pylori treatment medicine..
| Medienart: |
|
|---|
Patent| Erscheinungsjahr: |
2024 |
|---|---|
| Erschienen: |
2024 |
| Enthalten in: |
Europäisches Patentamt - (2024) vom: 05. Jan. Zur Gesamtaufnahme - year:2024 |
|---|
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
LIANG WU [VerfasserIn] |
|---|
| Links: |
Volltext [kostenfrei] |
|---|
| Anmerkungen: |
Source: www.epo.org (no modifications made), First posted: 2024-01-05, Last update posted on www.tib.eu: 2024-03-18, Last updated: 2024-03-22 |
|---|
| Patentnummer: |
CN117343874 |
|---|
| Förderinstitution / Projekttitel: |
|
|---|
| PPN (Katalog-ID): |
EPA001139568 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | EPA001139568 | ||
| 003 | DE-627 | ||
| 005 | 20240322141432.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 240322s2024 xx |||||o 00| ||eng c | ||
| 035 | |a (DE-627)EPA001139568 | ||
| 035 | |a (EPA)CN117343874 | ||
| 035 | |a (EPA)89362528 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 0 | |a LIANG WU |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Preparation method and application of lactobacillus paracasei IOB413 metagen extract product |
| 264 | 1 | |c 2024 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Source: www.epo.org (no modifications made), First posted: 2024-01-05, Last update posted on www.tib.eu: 2024-03-18, Last updated: 2024-03-22 | ||
| 520 | |a The invention provides a preparation method of a Lactobacillus paracasei IOB413 metagen extract product, the Lactobacillus paracasei IOB413 metagen extract product obtained by the method, and an application of the Lactobacillus paracasei IOB413 metagen extract product in preparation of Helicobacter pylori infection resisting related drugs. The lactobacillus paracasei IOB413 metagen extract product obtained by the method disclosed by the invention has the obvious effects of inhibiting the growth of helicobacter pylori, relieving the infection of the helicobacter pylori and improving flora disorder on mice infected by the helicobacter pylori; a certain pharmacological basis can be provided for adjuvant treatment of helicobacter pylori infection according to the casei paracasei IOB413 metaplasm extract product obtained by the method and functional verification of the product; and an effective thought is provided for developing the application of the lactobacillus paracasei IOB413 metagen extract product in the anti-helicobacter pylori treatment medicine. | ||
| 650 | 4 | |a bio | |
| 650 | 4 | |a C12P: Fermentation or enzyme-using processes to synthesise a desired chemical compound or composition or to separate optical isomers from a racemic mixture | |
| 650 | 4 | |a A61K: Preparations for medical, dental, or toilet purposes (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms a61j0003000000;chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles a61l; soap compositions c11d) | |
| 650 | 4 | |a C12N: Microorganisms or enzymes; compositions thereof; propagating, preserving, or maintaining microorganisms; mutation or genetic engineering; culture media (microbiological testing media c12q0001000000) | |
| 650 | 4 | |a A61P: Specific therapeutic activity of chemical compounds or medicinal preparations | |
| 650 | 4 | |a che | |
| 650 | 4 | |a C12R: Indexing scheme associated with subclasses c12c-c12q, relating to microorganisms | |
| 650 | 4 | |a 615 | |
| 700 | 0 | |a WANG HAIKUAN |4 aut | |
| 700 | 0 | |a HUANG LINLIN |4 aut | |
| 700 | 0 | |a HAN XUEMEI |4 aut | |
| 700 | 0 | |a FU TIANMIN |4 aut | |
| 700 | 0 | |a NA HONGJUN |4 aut | |
| 700 | 0 | |a SUN HAIWEI |4 aut | |
| 700 | 0 | |a SHI YALI |4 aut | |
| 700 | 0 | |a WANG FEI |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Europäisches Patentamt |g (2024) vom: 05. Jan. |
| 773 | 1 | 8 | |g year:2024 |g day:05 |g month:01 |
| 856 | 4 | 0 | |u https://worldwide.espacenet.com/patent/search/family/89362528/publication/CN117343874A1?q=CN117343874 |z kostenfrei |3 Volltext |
| 912 | |a GBV_EPA | ||
| 951 | |a AR | ||
| 952 | |j 2024 |b 05 |c 01 | ||